These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 320277)

  • 1. Experimental hematogenous endophthalmitis due to Candida: species variation in ocular pathogenicity.
    Edwards JE; Montgomerie JZ; Ishida K; Morrison JO; Guze LB
    J Infect Dis; 1977 Feb; 135(2):294-7. PubMed ID: 320277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental hematogenous endophthalmitis caused by Candida albicans.
    Edwards JE; Montgomerie JZ; Foos RY; Shaw VK; Guze LB
    J Infect Dis; 1975 Jun; 131(6):649-57. PubMed ID: 48529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo pathogenicity of eight medically relevant Candida species in an animal model.
    Arendrup M; Horn T; Frimodt-Møller N
    Infection; 2002 Oct; 30(5):286-91. PubMed ID: 12382088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative ocular pathogenicity of Cryptococcus neoformans, Candida glabrata, and Aspergillus fumigatus in the rabbit.
    Fujita NK; Henderson DK; Hockey LJ; Guze LB; Edwards JE
    Invest Ophthalmol Vis Sci; 1982 Mar; 22(3):410-4. PubMed ID: 7037676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental hematogenous candidiasis caused by Candida krusei and Candida albicans: species differences in pathogenicity.
    Anaissie E; Hachem R; K-Tin-U C; Stephens LC; Bodey GP
    Infect Immun; 1993 Apr; 61(4):1268-71. PubMed ID: 8454330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental and clinical studies of 5-fluorocytosine activity in Candida ocular infections. I. In vitro activity of 5-fluorocytosine on Candida species isolated from ocular infections.
    Segal E; Romano A; Eylan E; Stein R
    Chemotherapy; 1975; 21(6):358-66. PubMed ID: 1183243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of coagulase activity in pathogenic Candida species.
    Yigit N; Aktas AE; Ayyildiz A
    J Int Med Res; 2008; 36(6):1378-82. PubMed ID: 19094449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
    Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of experimental pathogenicity of Candida species in cyclophosphamide-immunodepressed mice.
    Bistoni F; Vecchiarelli A; Cenci E; Sbaraglia G; Perito S; Cassone A
    Sabouraudia; 1984; 22(5):409-18. PubMed ID: 6505914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pathogenicity of various Candida albicans and C. stellatoidea strains.
    Okawa Y; Miyauchi M; Takahashi S; Kobayashi H
    Biol Pharm Bull; 2007 Oct; 30(10):1870-3. PubMed ID: 17917253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of Candida species other than C. albicans as pathogens in oncology patients.
    Wingard JR
    Clin Infect Dis; 1995 Jan; 20(1):115-25. PubMed ID: 7727637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental hematogenous Candida endophthalmitis: diagnostic approaches.
    Henderson DK; Edwards JE; Ishida K; Guze LB
    Infect Immun; 1979 Mar; 23(3):858-62. PubMed ID: 457261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence assessment of six major pathogenic Candida species in the mouse model of invasive candidiasis caused by fungal translocation.
    Hirayama T; Miyazaki T; Ito Y; Wakayama M; Shibuya K; Yamashita K; Takazono T; Saijo T; Shimamura S; Yamamoto K; Imamura Y; Izumikawa K; Yanagihara K; Kohno S; Mukae H
    Sci Rep; 2020 Mar; 10(1):3814. PubMed ID: 32123235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of caspofungin against Candida guilliermondii and Candida parapsilosis.
    Barchiesi F; Spreghini E; Tomassetti S; Della Vittoria A; Arzeni D; Manso E; Scalise G
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2719-27. PubMed ID: 16870764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.
    Deren YT; Ozdek S; Kalkanci A; Akyürek N; Hasanreisoğlu B
    Can J Microbiol; 2010 Jan; 56(1):1-7. PubMed ID: 20130687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental systemic virulence of oral Candida dubliniensis isolates in comparison with Candida albicans, Candida tropicalis and Candida krusei.
    Koga-Ito CY; Komiyama EY; Martins CA; Vasconcellos TC; Jorge AO; Carvalho YR; do Prado RF; Balducci I
    Mycoses; 2011 Sep; 54(5):e278-85. PubMed ID: 20492535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus and candidiases.
    Dorko E; Baranová Z; Jenca A; Kizek P; Pilipcinec E; Tkáciková L
    Folia Microbiol (Praha); 2005; 50(3):255-61. PubMed ID: 16295665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of proteinase, phospholipase, hydrophobicity and biofilm forming ability in Candida species isolated from clinical specimens.
    Dabiri S; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    J Mycol Med; 2018 Sep; 28(3):437-442. PubMed ID: 29778633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroreactivities of proteinases of Candida albicans, C. tropicalis, and C. parapsilosis in sera from various Candida species-infected mice.
    Lee KH; Shin WS; Park HS; Park JY; Koh CM
    Yonsei Med J; 1997 Jun; 38(3):178-86. PubMed ID: 9259618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.